Internal Medicine Doctors in Hamilton, MT Accepting Medicare

9 Internal Medicine doctors found. Showing 1 - 9

Eugenie T Haight, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-5101    Fax: 406-363-7652

Dr. Jordan Judy, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211

Dr. Kathryn Elise Hurlbut, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211

John P Moreland, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-5101    Fax: 406-363-7652

John R Courchesne, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211    Fax: 406-375-4590

Anthony J Navone, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-375-4665    Fax: 406-375-4439

Romi Marie Coolidge, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-2211    Fax: 406-375-4846

Gary L Smith, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1224 W Main St, Hamilton, MT 59840 Phone: 406-363-1100    Fax: 406-363-2148

Lawrence A Hammond, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Westwood Dr, Hamilton, MT 59840 Phone: 406-363-5101    Fax: 406-363-7652

News Archive

Buphenyl may protect memory and prevent progression of Alzheimer's

Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.

United Cannabis files utility and PCT patent applications related to unique specifications of cannabinoids

United Cannabis Corporation today announced that it moved its provisional patent application to the next phase by filing a utility patent application related to the unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer with the U.S. Patent and Trademark Office.

Exposure to organochlorine compounds increases the risk of suffering colorectal cancer

A team of researchers at the Universitat Autònoma de Barcelona, The Catalan Institute of Oncology and the Higher Council for Scientific Research (CSIC) have published a study indicating that exposure to organochlorine compounds, which we ingest in our diets, increases the risk of suffering colorectal cancer.

Health Reform's Big Day: New consumer protections start now

Today marks the six month anniversary of enactment of the health reform law, and with it, a slew of consumer friendly provisions go into effect.

Low paid civil servants were more likely to develop type 2 diabetes

London civil servants at the lower end of the employment scale and with lower social position were more likely to develop type 2 diabetes than those at higher employment levels, according to an article in the September 27 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

Read more Medical News

› Verified 5 days ago